Insiders Pharvaris N.V.

Equities

PHVS

NL00150005Y4

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
20.57 ^USD	-1.34%		-12.58%	-26.67%

09/05	Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating	MT
08/05	Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharvaris N.V. Announces Chief Legal Officer Changes, Effective June 1, 2024	09/05	CI
Pharvaris Narrows Q4 Net Loss; Hires New CFO	11/04	MT
Pharvaris Appoints Stefan Abele as Chief Technical Operations Officer	15/11	CI
Pharvaris N.V. Announces Board Changes	03/23/03	CI
Pharvaris Announces the Promotion of Annick Deschoolmeester to Chief Human Resources Officer	30/22/30	CI
Pharvaris N.V. Appoints Joan Schmidt as Chief Legal Officer	11/22/11	CI
Pharvaris Announces Changes to its Board of Directors	22/21/22	CI
Pharvaris N.V. Announces Executive Changes	07/21/07	CI
Pharvaris Appoints Viviane Monges as Non-Executive Director	30/21/30	CI
Pharvaris Appoints Wim Souverijns as Chief Community Engagement & Commercial Officer, Effective July 1, 2021	12/21/12	CI
Pharvaris B.V. Appoints Peng Lu as Chief Medical Officer	07/20/07	CI
Pharvaris B.V. Announces Board Appointments	10/19/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW